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Abstract
Background: miRNAs are a class of small non-coding RNAs that regulate gene expression and have critical functions in
various biological processes. Hundreds of miRNAs have been identified in mammalian genomes but only a small number of
them have been functionally characterized. Recent studies also demonstrate that some miRNAs have important roles in
reprogramming somatic cells to induced pluripotent stem cells (iPSCs).
Methods: We screened 52 miRNAs cloned in a piggybac (PB) vector for their roles in reprogramming of mouse embryonic
fibroblast cells to iPSCs. To identify targets of miRNAs, we made Dgcr8-deficient embryonic stem (ES) cells and introduced
miRNA mimics to these cells, which lack miRNA biogenesis. The direct target genes of miRNA were identified through global
gene expression analysis and target validation.
Results and conclusion: We found that over-expressing miR-25 or introducing miR-25 mimics enhanced production of
iPSCs. We identified a number of miR-25 candidate gene targets. Of particular interest were two ubiquitin ligases, Wwp2 and
Fbxw7, which have been proposed to regulate Oct4, c-Myc and Klf5, respectively. Our findings thus highlight the complex
interplay between miRNAs and transcription factors involved in reprogramming, stem cell self-renewal and maintenance of
pluripotency.
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Introduction
Mouse and human fibroblast cells can be reprogrammed to
iPSCs by expressing the four Yamanaka factors: Oct4, Sox2, Klf4
and c-Myc [1,2,3,4,5,6,7]. Other somatic cell types have also been
reported to be reprogrammed to iPSCs [8,9,10,11,12]. Besides
retroviral vectors, alternative routes are used to deliver the genetic
factors such as lentivirus [2], adenovirus [13], plasmid-based
vectors [14], episomal vectors [15], and the piggyBac (PB) DNA
transposon [16,17]. A growing number of genetic factors and
chemical compounds are described to either improve reprogram-
ming or even to replace one of the Yamanaka factors
[18,19,20,21,22,23,24]. Moreover, perturbating several biological
processes such as the cell cycle and DNA repair has profound
effects on reprogarmming [25,26,27,28].
MicroRNAs function to promote target mRNA degradation or
as repressors of translation by binding the target sites usually
located in the 39 UTRs [29]. The long primary miRNAs (pri-
miRNAs) are processed by the microprocessor complex, composed
of the double-stranded RNA-binding protein DGCR8 and the
RNase III enzyme DROSHA, into short hairpins called precursor
miRNAs (pre-miRNAs) [30,31,32,33]. These hairpins are export-
ed to the cytoplasm and are processed by Dicer into mature
miRNAs [34,35]. Mouse ES cells express abundant miRNAs
which play important roles in ES cell biology. As a consequence
Dicer- or Dgcr8-deficient mouse ES cells are defective in cell cycle
progression and differentiation [36,37,38]. These defects can be
partially rescued by introduction of certain mature miRNAs. For
instance, introduction of a subset of the miR-290 cluster is able to
rescue the cell cycle defects in Dgcr8-deficient ES cells [39]. These
miRNAs, which include miR-291-3p, miR-294 and miR-295, are
thus named ES cell-specific cell cycle-regulating (ESCC) miRNAs
based on their ability to regulate G1-S transition [39]. Moreover,
proteins important in ES cell pluripotency are found to bind the
promoter regions of miRNAs and regulate their transcription
activities [40]. Therefore, miRNAs appear to have significant roles
at the centre of the regulatory networks that control pluripotency.
Indeed, overexpressing ESCC miRNAs can improve reprogram-
ming by replacing c-Myc [41], and expressing the miR-302 cluster
is sufficient to reprogram a cancer cell line to cells expressing
pluripotency genes [42]. In a dramatic show of miRNA’s function
in reprogramming, Morrisey and colleagues recently demonstrat-
ed that expressing the miR-302/367 cluster alone is sufficient to
reprogramme mouse and human fibroblast cells to iPSCs [43]. A
combination of mir-200c plus mir- 302 and mir-369 family
miRNAs is also shown to produce mouse and human iPSCs [44].
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Conversely, inhibition of the let-7 family, which silences ES cell
self-renewal by suppressing many of the same downstream targets
that are indirectly activated by the ESCC miRNA family,
promotes de-differentiation of somatic cells and reprogramming
[45].
To identify additional miRNAs that affect reprogramming, we
performed a genetic screen focusing on miRNAs that are
expressed in mouse ES cells [46,47], or over-expressed in cancer
[48,49]. From this screen, we found that overexpressing miR-25
substantially improved reprogramming, which was confirmed by
introducing miR-25 mimics. The iPSCs produced were fully
pluripotent as they contributed efficiently to both somatic cells and
the germline in chimeras. Moreover, through bioinformatics
analysis and experimental validation, we identified that miR-25
directly regulated Wwp2, an E3 ubiquitin ligase that targets Oct4
for ubiquitination, and Fbxw7, which is known to regulate c-Myc,
Klf5 and other important factors. These results thus reveal a
mechanism for miR-25 to regulate pluripotency genes and provide
new information for efficient reprogramming.
Results
MicroRNAs that promote reprogramming
The piggyBac (PB) transposition works efficiently in mammalian
cells. We have previously comprehensively characterized PB
transposition in mammalian cells and used it in reprogramming
experiments [16,50,51]. To start exploring the roles of miRNAs in
reprogramming, we selected 52 miRNAs or miRNA clusters,
based on their expression in ES cells or in tumour cells (Table S1)
[46,47,48,49]. These miRNAs were cloned in the PB vector by
PCR-amplifying 500–800 bp genomic DNA fragments that
encompass the ‘precursor’ miRNA sequences (Table S2). In these
PB vectors, miRNA expression was under the control of the CAG
promoter (PB-CAG-mir) (Fig. 1a).
ES cell pluripotency requires proper levels of Oct4 (Pou5f1)
expression [52], and activation of Oct4 is a critical event in the
reprogramming process [4]. We constructed and used an Oct4-
reporter mouse line where an IRES-PuroGFP cassette was targeted
to the 39 UTR of the Oct4 locus (Fig. 1b) [51]. Fully pluripotent
iPSCs reprogrammed from these Oct4-reporter MEFs are resistant
to 2.0 mg/ml puromycin (Puro) selection and identifiable as GFP+
in flow cytometry [51]. Therefore we use resistance to 2.0 mg/ml
Puro or GFP expression to assess primary reprogrammed colonies,
followed by comprehensive characterization.
To reprogram mouse embryonic fibroblasts (MEFs) to iPSCs,
we constructed the PB transposon carrying the four Yamanaka
factor cDNAs controlled either by the CAG promoter (PB-CAG-
OCKS, for Oct4, cMyc, Klf4 and Sox2) for constitutive
expression, or by the Tet-response element (PB-TRE-OCKS) for
inducible expression by Doxycycline (Dox) (Fig. 1a). As the
baseline reprogramming control, we transfected the PB-CAG-
OCKS transposon to Oct4-reporter MEFs, and plated the cells on
STO feeder cells (Fig. 1c). To examine the effects of miRNAs in
addition to the Yamanaka factors on reprogramming, we co-
transfected the PB-CAG-OCKS plasmid with each of the 52 PB-
CAG-miRNA plasmids and selected the reprogrammed colonies
for puromycin resistance (2.0 mg/ml). We usually began Puro
selection 10 days after transfection when ES cell-like colonies
started to appear. Puror colonies were subsequently picked for
expansion and further analysis.
Four out of the 52 tested miRNAs or miRNA clusters: the miR-
302 cluster, miR-25, miR-290 and miR-298, gave substantially
more Puror iPSC colonies (2–4 fold) than the control where only
the four factors were used (PB-CAG-OCKS) (Fig. 2a). Identifica-
tion of miR-302 and miR-290 in our screen confirmed the
previous studies [41,42]. However, we were unable to reproduce
the result reported by Morrisey and colleagues [43] that expressing
the miR-302/367 cluster alone is sufficent to reprogramme MEFs
to iPSCs. This discrepancy is possibly caused by the miRNAs
delivery approaches. We used the PB transposon where miR-302/
367 cluster expression was controlled by the CAG promoter
whereas in Morrisey’s work, this cluster was delivered using a
lentiviral vector. However, this possibility needs to be further
investigated experimentally. Although miR-290 itself was not
known to promote reprogramming, several members of the miR-
290 family, miR-291-3p, miR-294 and miR-295, enhance
reprogramming of MEFs in the absence of c-Myc [41]. The other
two miRNAs identified in this screen, miR-25 and miR-298, were
not previously reported for their role in ES cells or in
reprogramming when the project started. We therefore chose
initially to further characterize miR-25 since it was found to be
expressed in ES cells (Fig. 2b), and its mature sequence is
conserved across all vertebrate genomes examined (Table S3). On
the other hand, miR-298 expression was not found in ES cells
[47].
To confirm the effects of miR-25 over-expression on repro-
gramming, we transfected 16106 MEFs with PB-TRE-OCKS,
PB-CAG-rtTA and PB-CAG-mir25 (Fig. 1a). Dox was added to
the culture media to induce expression of the four Yamanaka
factors. Again expression of miR-25 substantially increased the
number of Puror iPSCs (Fig. 2c–d). The iPSC colonies were picked
16 days after transfection, and initially expanded in M15 plus LIF
media. Dox was subsequently removed from the culture during
colony expansion and the medium was changed from M15 plus
LIF to the 2i medium. This medium is considered to be able to
select and maintain ground state or naı¨ve pluripotent ES cells by
inhibiting the activities of ERK and GSK3b [53]. iPSCs produced
from using either the 4 Yamanaka factors (4F-iPSC) or 4F plus
miR-25 (25-iPSC) proliferated well in the 2i medium. Consistent
with their resistance to 2.0 mg/ml Puro, the cells also expressed
GFP in flow cytometry thus demonstrating robust expression of
the endogenous Oct4 locus (Fig. 2e).
The miR-25 genomic DNA cloned in the PB also contains miR-
93 (Table S2). However, we did not detect noticeable effect on
reprogramming by expressing miR-93 from another genomic
DNA containing only miR-93 (Table S2). To further examine the
specific effect of miR-25 on reprogramming, we repeated the
above reprogramming experiments using a miR-25 mimic instead
of the genomic DNA containing miR-25. Adding miR-25 mimic
increased AP+ colony number similar to using PB-CAG-mir-25/
93 (Fig. 2C)
Characterization of iPSCs produced by over-expressing
miR-25
Dox induced iPSCs of both 4F-iPSC and 25-iPSC were
expanded for over 20 passages in the 2i medium without Dox.
Both iPSCs expressed pluripotency markers as well as a panel of
pluripotency-associated genes at levels comparable with that in ES
cells (Fig. 3a and 3b). However, compared to MEFs and 4F-iPSCs,
25-iPSCs expressed higher levels of miR-25 (Fig. 2b). Bisulphite
genomic DNA sequencing analysis of the promoter regions of Oct4
and Nanog loci revealed extensive demethylation in both 25-iPS
and 4F-iPS cells as seen in ES cells, thus further confirming
activation of these pluripotency gene loci (Fig. 3c). Importantly,
even after extensive in vitro passage, these iPSCs retained a normal
karyotype (Fig. 3d). To ensure that the exogenous factors were not
expressed in the absence of Dox, we designed primers to amplify
junction fragments between the Yamanaka factor cDNAs in PB-
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TRE-OCKS, and performed RT-PCR using RNA samples from
iPSCs growing in the presence or the absence of Dox. As shown in
Fig. 3e, Dox induced robust expression of the Yamanaka factors,
while withdrawing Dox completely shut down their expression in
the majority of examined iPSC lines (Fig. 3e).
To determine differentiation potentials of iPSCs, we injected
4F- and 25-iPSCs into F1 mice of C57BL/6 and 129S5 because
Oct4-reporter MEFs had a C57BL/6/129S5 mixed genetic
background. Both 4F- and 25-iPSCs efficiently formed teratomas
containing tissues of all three germ layers (Fig. 3f). The 4F- and 25-
iPSCs were also injected to C57BL/6 (albino) blastocysts for
chimera production. Chimeras with extensive donor cell contri-
bution were obtained from both iPSCs (Fig. 3g). Two male
chimeras produced from injecting 25-iPSCs were crossed to wild
type C57BL/6 (albino) females to test germline contribution of the
iPSCs in the chimeras. In the first eight litters, 50 out of 52 pups
were agouti coat colour indicative of very efficient contribution of
25-iPSCs in the germline of the chimeras (Fig. 3g). Similarly, two
Figure 1. Reprogramming MEFs using PB transposons carrying the four Yamanaka factors and miRNAs. a. Schematic diagrams of the
PB transposon constructs. Mouse cDNAs for Oct4, c-Myc, Klf-4 and Sox2 (OCKS) were cloned under the control of either the CAG promoter or the TRE
(Tet responsive element). Expression of rtTA (reverse tetracycline transactivator) and the miRNAs was controlled by the CAG promoter. cDNAs of
OCKS were joined by a linker encoding the 2A peptide. b. The Oct4-reporter allele. The IRES-PuroGFP cassette was targeted to the 39 UTR of Oct4
locus, immediately after the TGA stop codon in exon 5. c. Timeline of the reprogramming strategy. MEF cells were transfected with the transposon
constructs and plated onto STO feeder cells. Puromycine (2.0 mg/ml) was added to select for Oct4 expression on day 10. If the Dox-inducible
transposon (PB-TRE-OCKS) was used, Dox (1.0 mg/ml) was added one day after transfection.
doi:10.1371/journal.pone.0040938.g001
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male chimeras produced from 4F iPSCs were also crossed to wild
type C57B6 females (albino). Out of total 32 pups in the first four
litters, 24 were agouti. Since the Dox induced iPSCs did not
express detectable levels of exogenous factors in the absence of
Dox (Fig. 3E), chimeras derived from either 4F- or 25-iPSCs did
not develop any tumour or abnormalities in the aging period (14
months, n = 10).
To further characterize the 4F- and 25-iPSCs, we performed
genome-wide gene expression microarray analysis. Expression
profiles of 4F-iPSCs and 25-iPSCs were highly correlated, and
clustered together with the profiles of ES cells and distinct from
those of MEFs (Fig. 4a and b).
Identification of miR-25 targets
Dgcr8 is a critical component of the complex that processes
primary miRNAs. Dgcr8-deficient ES cells have defects in miRNA
biogenesis [38]. These cells thus provide an ideal platform to
facilitate identifying potential miRNA targets once a mature
miRNA is introduced into these ES cells. The obvious advantage
of this system over transfecting miRNA mimics in another cell type
(e.g. HeLa or normal ES cells) is that the target sites are not
saturated by the endogenous miRNAs and there will be no
functionally redundant miRNAs to confound the results.
We thus used a Dgcr8-deficient ES cell line where one allele was
mutated by gene trapping and the other allele contained a targeted
gene trap cassette (Davis et al. co-submission with this manuscript).
To identify the direct target genes of miR-25, we introduced either
a mimic version of miR-25 or a control miRNA (C. elegans
miRNA, cel-miR-239b) (Fig. 5a) into the Dgcr8-deficient ES cells
and generated gene expression profiles using Illumina BeadChip
microarrays. Potential miR-25 target genes were expected to be
down-regulated in cells with the miR-25 mimic but not in control
cells. We used Sylamer to further characterise the effect of miR-25
expression [54]. Briefly, Sylamer tests for miRNA effects by
searching sorted lists of genes for enrichment or depletion of words
complementary to all possible miRNA ‘‘seed’’ regions, which are
the most important determinants of target specificity. The 39UTR
sequences of all the transcripts profiled on the microarrays were
Figure 2. Co-expressing OCKS and microRNAs improved reprogramming. a. Four microRNAs: miR302 (cluster), miR-25/93, miR-290 and
miR-298 were able to improve reprogramming. Shown here is the fold change of iPSC colony number (2.0 mg/ml Puror). Fold changed was calculated
based on the iPSC colony number using the four factors only (mean 6 SEM. N=4). b. qPCR analysis of the mature form of miR-25 expression.
Expression was determined by qPCR and normalized using Sno202 miRNA. Data are mean 6 SEM from three cell lines. * P,0.05. c. Reprogrammed
colonies (2.0 mg/ml Puror) stained either by Methylene blue or for Alkaline Phophatase activity (AP). NC: negative control using a PB-Neo plasmid with
no reprogramming factors; 4F-iPSC: iPSCs reprogramming by expressing OCKS (Dox inducible); 25-iPSC: iPSCs reprogramming by expressing OCKS
(Dox inducible) and miR-25. Mimic: Transfection used a miR-25 mimic instead of the PB-CAG-mir25. d. A primary iPSC colony reprogrammed with the
four Yamanaka factors and miR-25. e. GFP expression from the Oct4 locus in 4F-iPSCs and 25-iPSCs detected by flow cytometry.
doi:10.1371/journal.pone.0040938.g002
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sorted starting with the most down-regulated in the miR-25
transfection experiment. The only 7mers that were enriched
within the 39UTRs of these down-regulated genes correspond to
words complementary to the miR-25 seed sequence, indicating
that the experimental profile can be used to derive lists of genes
enriched for direct targets of miR-25 (Fig. 5b). From this
experiment we obtained a list of 72 transcripts, which were
down-regulated after transfection of the miR-25 mimic, with a fold
change of at least 1.2 and with an estimated false discovery rate
less than 10%. Of these genes, 54 possessed at least one seed-
matching site for miR-25 in their 39UTR and constitute the initial
set of experimentally derived miR-25 targets (Table S4). To test if
these targets are being actively repressed by miR-25 in our iPSCs,
we compared the 25-iPS microarray samples against the 4F-iPS
samples. We observed that these miR-25 candidate targets were
down-regulated in the 25-iPS cells (p value 961024 by a Wilcoxon
signed-rank test) (Fig. 5C). From these targets, we prioritized a list
of 12 gene by selecting those that were also up-regulated in the
Dgcr8-deficient cells, besides being down-regulated in 25-iPSCs
relative to 4F-iPSCs (Table 1). Of particular interest on this gene
list were Wwp2 and Fbxw7, which have been shown to modulate
Oct4 and c-Myc respectively [55,56,57,58,59,60].
Figure 3. Characterization of 25-iPSCs. a. Immunofluorescence-staining of iPSCs to detect SSEA1 and Nanog expression. DNA was stained with
DAPI (blue). b. RT-PCR analysis of pluripotency gene expression in 25-iPSCs and 4F-iPSCs. MEFs and ES cells serve as the negative and positive
controls, respectively. Beta-actin was used as the PCR control. dH2O: no DNA template. c. Bisulfide genomic sequencing of the promoter regions of
Oct4 and Nanog loci to detect CpG methylation. Open and filled circles represent unmethylated or methylated CpG dinucleotides, respectively. d.
Normal karyotypes in a male 4F-iPS cell and a male 25-iPS cell. e. No exogenous Yamanaka factor expression in 25-iPSCs. RT-PCR was performed using
primers to amply OCKS junctions (Primer sequences are in Table S2). Robust expression from PB-TRE-OCKS was detected in the presence of Dox. No
expression was found if Dox was removed from the media. +RT: reverse transcriptase; -RT: no reverse transcriptase in reverse transcription. Beta-actin
was used as the PCR control. f. Haematoxylin eosin stained sections of teratomas derived from 25-iPSCs. Cells representing all three germ layers were
readily identifiable. g. Germline-transmission pups (agouti) from two chimeras derived from 25-iPSCs that were crossed to wild-type C57BL6 (albino)
females.
doi:10.1371/journal.pone.0040938.g003
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Validation of wwp2 and fbxw7 as miR-25 targets
We next proceeded to validate the experimentally predicted
miR-25 targets. We first used quantitative (real-time) RT-PCR
(qRT-PCR) to examine the expression of two selected miR-25
targets, Wwp2 and Fbxw7, as well as the pluripotency markers Oct4
and Nanog in MEF, 4F-iPSCs, 25-iPSCs and mouse ES cells. No
significant difference in the expression of Oct4 or Nanog was
detected, possibly due to the tightly regulated expression of
pluripotency genes in ES cells and in iPSCs. Wwp2 is expressed at
much higher levels in MEFs than in ES cells (Fig. 6a). The level of
the Wwp2 transcript was significantly lower in 25-iPSCs compared
to 4F-iPSCs, and was comparable to that in ES cells (Fig. 6a).
Although we consistently detected lower Fbxw7 expression in 25-
iPSCs and ES cells than in 4F-iPSCs, this decrease was not
statistically significant (Fig. 6a). The expression results were thus
consistent with the predictions of Wwp2, and to a certain degree
Fbxw7, as the potential targets of miR-25.
To demonstrate that miR-25 directly regulates Wwp2 and
Fbxw7, we performed the luciferase reporter assay based on
pmirGLO Dual-Luciferase system where the full-length 39UTR of
either Wwp2 or Fbxw7 was inserted into the 39 side of the firefly
luciferase gene (luc2) (Fig. 6b–c).
The wild type 39 UTR of Wwp2 carries one miR-25 target site.
We introduced a point mutation into this target site, which would
abolish miR-25 binding based on computational prediction. The
reporter plasmids carrying either the wild type or the mutant 39
UTR of Wwp2 were co-transfected with the miR-25 mimics or the
negative control mimics into HeLa S3 cells. The negative control
mimics did not have any significant effect on reporter activity.
However, the miR-25 mimic significantly repressed luciferase
activity from the wild type reporter plasmid (Fig. 6d). Once the
miR-25 binding target site was mutated, the repressing effect of the
miR-25 mimic was lost (Fig. 6d). These results thus confirmed the
critical role of the miR-25 binding site in regulating the luciferase
activity in the reporter plasmid and thus Wwp2.
The 39 UTR of Fbxw7 has two miR-25 binding sites. Point
mutations were subsequently introduced into both sites in the
mutant reporter plasmid. Again, we co-transfected the reporter
plasmids with the miR-25 mimics and the negative control mimic
into HeLa S3 cells. The negative control mimic did not show any
effect on the reporter activity, whereas the miRNA-25 mimics
caused significant repression on the luciferase activity from the
wild type reporter but not the mutated reporter (Fig. 6d). These
data thus confirmed Fbxw7 as another direct target of miR-25.
Figure 4. Genome-wide gene expression analysis in iPSCs and ES cells. a. Heatmap showing the (log2) absolute expression intensities in
MEFs, 25-iPS, 4F-iPS and ES cells of the top 100 differentially expressed genes between MEFs and ES cells. Expression profiles are clustered based on
correlation, and the dendrogram represents the relationship between different cell types. b. Venn diagram showing the number of shared
differentially expressed genes among 25-iPSCs, 4F-iPSCs and ES cells when compared to MEFs.
doi:10.1371/journal.pone.0040938.g004
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Discussion
In an effort to identify new genetic factors in reprogramming,
we screened 52 miRNAs/clusters that are expressed in ES cells or
over-expressed in cancer. Two candidates, miR-25 and miR-298,
were found to substantially improve reprogramming with the four
Yamanaka factors. We focused on characterizing miR-25 in this
study as miR-25 had a strong phenotype in promoting
reprogramming, is highly conserved during evolution and is
expressed in ES cells. The iPSCs produced by overexpressing
miR-25 together with the four Yamanaka factors were pluripotent
stem cells, based on their gene expression profiles, and on their
ability to contribute to both the somatic lineages and the germline
in chimeras. Further experiments designed to elucidate the
contribution of miR-25 to this process combining computational
prediction and experimental analysis using Dgcr8-deficient ES cells,
demonstrated that miR-25 regulates a number of genes in mouse
ES cells. We chose Wwp2 and Fbxw7 for further analysis and
confirmed that miR-25 directly regulated Wwp2 and Fbxw7 in the
luciferase reporter assay.
Wwp2, an E3 ubiquitin ligase, promotes Oct4 degradation by
ubiquitination in both mouse and human ES cells [55,56], thus
suggesting a potential mechanism for improving reprogramming
efficiency by miR-25. Importantly, Wwp2 expression levels in 25-
iPSCs were slightly but consistently lower than that in iPSCs
reprogrammed by the four Yamanaka factors alone (Fig. 6a). We
did not however detect an obvious increase of Oct4 protein levels
in 25-iPSCs (data not shown). The stable Oct4 expression level is
likely caused by the pluripotent gene expression regulatory circuit
in iPSCs where Oct4 is regulated by multiple factors. Fbxw7, on
the other hand, is a component of SCF ubiquitin ligases that
catalyzes the ubiquitination of cyclin E, Notch, c-Jun and c-Myc
[57,58,59,60]. Interestingly, Fbxw7 also directly targets Klf5 for
ubiquitination and degradation [61]. Klf2, Klf4, and Klf5 are the
core KLF protein circuitry with redundant function in regulating
self-renewal of ES cells and Nanog expression [62], and Klf2 and
Klf5 can replace Klf4 in reprogramming [63]. Thus, repression of
Fbxw7 induced by over-expression of miR-25 might also
contribute to improving reprogramming through upregulation of
Klf5. While this manuscript was under preparation, miR-25 was
Figure 5. Identification of miR-25 targets. a. Timeline of miR-25 mimic transfection into the Dgcr8-deficient ES cells for discovering transcripts
that were repressed by miR-25. The C. elegans miRNA, cel-miR-239b, was used as the negative control. b. Sylamer plots following the analysis of
microarray data. The x-axis represents the 39UTR sequences of all transcripts, sorted from the most down-regulated after miR-25 transfection
compared to the cel-miR-239b transfection. Sylamer was used to analyze the enrichment or depletion of all possible heptamers matching mouse
miRNA seeds, at every 500 sequences of the gene list. The horizontal dashed lines denote Bonferroni corrected p-value thresholds of 0.05. Words
matching the mmu-miR-25 and cel-miR-293b seeds are highlighted. c. Cumulative fraction plot of the fold-changes obtained by comparing 25-iPS vs
4F-iPS microarrays. The fold-changes for all genes are indicated by the black curve; the green curve represents the 54 miR-25 targets from Table S4.
doi:10.1371/journal.pone.0040938.g005
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Figure 6. Validation of miR-25 targets. a. Realtime RT-PCR analysis of expression of Oct4, Nanog, Wwp2 and Fbxw7 in MEFs, iPSCs and ES cells. A
significant decrease of Wwp2 was detected in 25-iPSCs, compared to 4F-iPSCs. Gene expression was normalized against Gadph. Error bar (mean 6
SEM. N=3 cell lines). * P,0.05 compared with 25-iPS cells for Wwp2 expression. b–c. Luciferase reporter assay to the validate miR25 binding sites in
the 39UTRs of Wwp2 and Fbxw7. Schematic diagrams of the reporters for Wwp2 (b) and Fbxw7 (c). The wild type and mutated miR-25 binding sites
(highlighted in red) were indicated. The 39 UTR of Wwp2 has one miR-25 binding site, whereas Fbxw7 has two. The 39UTR genomic regions amplified
for bothWwp2 and Fbxw7 are about 1.6 kb. d. Luciferase reporter assays for validatingWwp2 and Fbxw7 as direct targets of miR-25. Wild-type (Wt) or
Mutant (Mut) reporter plasmids were co-transfected with miR-25 mimic or a control mimic into HeLa S3 cells to assay for the miR-25 dependent
repression of Wwp2 and Fbxw7 reporter. Data are presented as mean 6SEM (N=3). Comparison between groups were performed using one-way
ANOVA followed by the Newman-Keuls post test to determine statistical significance. ** P,0.001.
doi:10.1371/journal.pone.0040938.g006
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shown to directly regulate p53 in tumour cells, and possibly p21
and Tgfb signalling in MEFs [64,65]. Both p53 and Tgfbare
implicated in reprogramming [66,67]. MiR-25 has also been
recently suggested to function in IGF signalling, Wnt signalling
and apoptosis in several cell types [68,69,70,71]. In this study, we
identified a different set of miR-25 targets in Dgcr8-deficient
mouse ES cells. These targets include Wwp2 and Fbxw7, which
may regulate three of the four reprogramming factors, Oct4, cMyc
and Klf5. Other miR-25 targets identified in this study still remain
to be characterised for their role in reprogramming. Our results,
together with the other studies, show that, miR-25 promotes
reprogramming by several mechanisms and possibly at distinct
reprogramming stages. Given the conservation of miR-25 mature
sequence during evolution and its role in regulating pluripotency
genes, it will be interesting to determine whether its role is
conserved in reprogramming human cells.
Materials and Methods
Ethics statement
All animal experiments were performed in accordance with the
UK’s 1986 Animals Scientific Procedure Act and local institute
ethics committee regulations. Wellcome Trust Sanger Institute
Ethical Review Committee approved this study.
Construction of transposon plasmids encoding
microRNA and the 4 factors
Candidate miRNAs were selected from published papers based
on their expression in mouse ES cells, in the mouse oocyte or in
cancer [40,42,46,47,48,49,77,78,79,80,81,82,83,84] (Table S1).
Genomic DNA fragments harbouring miRNAs were cloned into a
PB vector carrying a CAG promoter-driven expression cassette
(PB-CAGG-miRNA). cDNAs of Oct4, Sox2, Klf4 and c-Myc were
cloned into a PiggyBac vector under either the control of the CAG
promoter or the Tetracycline operator (PB-CAG-OCKS and PB-
TRE-OCKS). The cDNAs of the 4 factors were generated by
PCR amplification to insert 2A peptide sequence in between the
four cDNAs. A separate PB vector, with M2rtTA insert was also
cloned under the tetracycline operator (PB-TRE-rtTA). All
plasmids had the pBlueScript backbone.
Reprogramming of MEFs and iPS cell culture
MEFs with Oct4-GFP-Puro reporter allele were prepared from
13.5 d.p.c. embryos (C57BL/6 and 129S5 F1) cultured in M10
media: DMEM containing 10% FBS (HyClone), 1,000 units/ml
Penicillin, 1,000 ug/ml Streptomycin, 2.92 mg/ml L-Glutamine
and 16 non essential amino acids (Invitrogen). Individual PB-
miRNAs were co-transfected with PB-OCKS into MEFs. Elec-
troporation was performed using an Amaxa device to introduce
2 mg of PB-CAG-OCKS transposon and 2 mg of PB-CAG-
miRNA transposon. The cells were then allowed to be
reprogrammed to iPSCs in normal ES cell M15 media: DMEM
containing 15% of FBS (Hyclone), 1,000 units/ml Penicillin,
1,000 ug/ml Streptomycin, 2.92 mg/ml L-Glutamine, 16 non
essential amino acids, 0.1 mM 2-mercaptoethanol and
1,000 Uml21 Leukemia inhibitory factor (LIF, Chemicon). For
the Tet-inducible system, a PB-Tet-OCKS was co-electroporated
with 1.0 mg of PB-CAG-rtTA plasmid. After 10 days of
Doxycyclin induction, Puromycin selection (2.0 mg/ml) was
applied. The plates were stained with methyl Blue or for Alkaline
Phosphatase activities to score iPSC colonies. The iPSC colonies
were cultured for 4 days in 2i media (iSTEM, Stem cell sciences).
All ES cells and iPSCs were cultured on Mitomycin C–treated
STO feeder cells.
Transfection of the miR-25 mimics in reprogramming
MEF cells were transfected with 2.0 mg of PB-CAG-OCKS
plasmid, together with 16 nM of miRNA-25 mimic (Dharmacon)
using the Amaxa transfection device. At 3, 6 and 9 days post initial
transfection, these cells were transiently transfected with 16 nM of
miRNA-25 mimic (Dharmacon) with Lipofectamin 2000 (Invitro-
gen) according to manufacture’s instructions. Reprogrammed
colonies were stained with Alkaline Phosphate.
Dgcr8-deficient ES cell lines were maintained in GMEM media
supplemented with 100 mg/ml hygromycin B (Calbiochem). These
cells were split every 2–3 days as they approached confluency.
Flow cytometry
Flow cytometric analysis was performed using iPSCs growing in
96-well plates to detect the GFP expression under the Oct4
promoter. We used a Cytomics FC500 series (Beckman Coulter) in
this work.
RT-PCR
Reverse transcription reactions were performed using Super-
Script II (Invitrogen) and the Oligo dT20 primer. PCR was then
carried out using the primers for ES cell marker genes listed in
table 1 and an Extensor Hi-Fidelity PCR master mix 2 (ABgene).
PCR was performed using the following settings: 94uC for 4 min,
followed by 30 cycles of 94uC for 30 sec, 65uC for 30 sec and
68uC for 45 sec. Final incubation was at 68uC for 10 min.
Real time PCR
Quantitative real time PCR was performed using Taqman
Gene Expression assays (Applied Biosystems) according to
manufacture’s instructions. The amount of target RNA was
determined from the appropriate standard curve and normalized
relative to GAPDH mRNA. The assay was custom designed using
the Primer Express Software 3.0 (Applied Biosystems).
Immunostaining
IPSCs were fixed with 4% paraformaldehyde in PBS for 20 min
at room temperature (16–25uC) and permeabilized in 0.2% Triton
in PBS for 10 min at room temperature. Cells were then blocked
by incubation for 20 min with 5% donkey serum in PBS at room
temperature. Cells were washed three times with PBS before the
addition of PBS containing antibodies against Nanog (1:500,
Rabbit polyclonal; ab21603, Abcam) and SSEA1 (1:100, mouse
monoclonal, MC80; Cell Signaling Technology). After incubation
for 1 hour at room temperature, cells were then washed 3 times
with PBS and labelled with Alexa 488- or Alexa 546-conjugated
secondary antibodies (Invitrogen). After a final wash with PBS, a
drop of Vectashield (containing DAPI) mounting solution was
applied to the slide and a coverslip fitted. The samples were then
analyzed using a LSM700 confocal microscope (Zeiss) according
to manufacture’s instructions.
Bisulfide genomic sequencing
The promoters of Oct4 and Nanog were analyzed using bisulfide
genomic sequencing for the DNA methylation status of MEF, 4F-
iPS, 25 iPSCs and ES cells. The bisulfide treatment was performed
using the CpGenome modification kit (Qiagen) according to
manufacture’s instructions. The PCR primers for Oct4 and Nanog
were similar to those described previously by Takahashi and
Yamanaka.
Oct4 F: ATTTGTTTTTTGGGTAGTTAAAGGT
Oct4 R: CCAACTATCTTCATCTTAATAACATCC
Nanog S: TGGTTAGGTTGGTTTTAAATTTTTG
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Nanog AS: AACCCACCCTTATAAATTCTCAATTA
PCR products were cloned into pGEM T-vector (Promega) and
sequenced using the M13 forward and reverse primers.
Teratoma
iPSCs were. F1 mice of C57BL/6 and 129S5 were anesthetized
with diethyl ether. 16106 iPSCs resuspended in PBS were
administered subcutaneously into the dorsal flank. Tumours were
visible 3 to 5 weeks after the injection, which were surgically
dissected from the mice. Samples were weighed, fixed in PBS
containing 4% formaldehyde, and embedded in paraffin. Sections
were prepared and stained with hematoxylin and eosin.
Microarray analysis
Total RNA from MEFs, ES cells or iPSCs were hybridized onto
MouseWG-6 expression BeadChip (Illumina) according to man-
ufacture’s instructions. Arrays were then scanned using the
BeadXpress Reader (Illumina). Raw expression files were exported
directly from BeadStudio and loaded into R/Bioconductor [72].
The lumi package was used to perform Vanriance-stabilizing
Transformation and Robust Spline Normalization on the expres-
sion values [73]. For analysis of differential expression, limma was
used to fit linear models to every probe, using an empirical Bayes
approach to shrink the estimated variance [74,75]. Probes that
passed a detection threshold ,0.01 in at least one sample (these
values are included in Illumina’s BeadStudio output) were called
‘present’. To establish False Discovery Rates (FDR), the p-values
of all the ‘present’ probes were adjusted using the Benjamini and
Hochberg method. To highlight the similarities and differences
between different cell types, a FDR of 10% was chosen as a cut-off
point.
Identification of potential miR-25 targets
The homozygous mutant cells were used for analysis as follows.
Dgcr8gt1/tm1 mouse embryonic stem cells were maintained in
100 mg/ml hygromycin B (Calbiochem) selective ES cell culture
medium (500 ml GMEM (Sigma), 50 ml Foetal Bovine Serum
(Gibco), 5 ml 200 mM L-Glutamine (Gibco), 5 ml 100 mM
Sodium Pyruvate (Gibco), 5 ml 1006Non-Essential Amino Acids
(Gibco), 70 ml 0.05 M ß-mercaptoethanol (Sigma) and LIF) in
gelatinized plates. Prior to transfection the cells were cultured for 4
days in non-selective media. On the fourth day the cells were
plated to gelatinised 6 well plates, 966104 cells per well in 7.2 ml
of non-selective media. Wells were transfected after 3 hours. 240
pmoles of miRNA control mimic (miRIDIAN Negative Control
#2 (Dharmacon CN-002000-01-05) or miRIDIAN mmu-miR-25
mimic (Dharmacon C-310564-01-0005)) were added to 240 ml
OptiMEM I (Gibco). 7.2 ml of Lipofectamine 2000 (Invitrogen)
was added to further 240 ml of OptiMEM and incubated for
5 minutes at room temperature. The two mixtures were subse-
quently combined. This mixture was incubated for 25 minutes at
room temperature. Then the media in each well was replaced by
2.4 ml of fresh, non-selective media. The miRNA-lipid complexes
were transferred to the wells and these were mixed gently. 5 hours
later, the media was replaced with a further 7.2 ml of non-selective
media. 10 hours after the initiation of transfection cells were
washed twice with DPBS (-CaCl2 and MgCl2) (Gibco) and lysed
with 1 ml of Trizol. Transfections were conducted in duplicate.
Purified RNA was cleaned up with an RNeasy MiniElute Cleanup
Kit (Qiagen) and labeled using the Total Prep RNA Amplification
Kit (Illumina). 1500 ng of biotinylated RNA was hybridised to
Illumina Mouse-6 v1.1 Expression Beadchips overnight at 58uC.
The chips were washed, detected and scanned according to the
manufacturers instructions and the scanner output was imported
into Beadstudio v.3.1.8 (Illumina).
In addition Trizol was used to prepare RNA in triplicate from
the 2 independently derived homozygous mutant mouse ES cell
lines (Dgcr8gt1/tm1 and Dgcr8gt2/tm1) and 2 corresponding heterozy-
gous cell lines (Dgcr8tm1,gt1/+ and Dgcr8tm1,gt2/+). The RNA was
prepared for array analysis as described above.
Microarray analysis was conducted in R/Bioconductor [72]
using the lumi [73] and limma [74] packages. All arrays relevant for
this study were vst [75] transformed and quantile normalised
alongside further array sets, the results of which will be discussed in
a subsequent paper (Davis et al in preparation). The probes from
the array were mapped to transcripts based upon the annotation of
Ensembl v53. Where a probe maps to multiple transcripts, Vega
[76] annotation was accepted in preference followed by Ensembl
transcripts and EST transcripts respectively. In each category the
transcript with the longest 39UTR was chosen. If a probe was not
associated with an Ensembl annotated transcript, where possible
probes were annotated with a transcript according to the Illumina
annotation file. Only probes with an annotated transcript were
considered for the expression analysis. Where multiple probes
mapped to the same transcript, the probe with the greatest inter-
quartile range across the normalised arrays was selected for
expression analysis. In order to determine a list of transcripts
down-regulated by miR-25 a linear model was fitted across a large
set of similar experiments prior to the comparison of the relevant
samples (Davis et al in preparation); these include arrays
considering a transfection time series and the transfection of
alternative miRNAs. Arrays derived from Dgcr8gt1/tm1 cells
transfected with a miR-25 mimic, lysed 10 hours after transfection
were compared to those derived from cells transfected with a
control mimic lysed after the same interval. Probes down-
regulated in the presence of the miRNA mimic with a log fold
change greater than log2(1.2) and a p-value less than 0.1 were
considered for further analysis.
The transcripts associated with these probes were mapped to
further annotation based upon Ensembl version 53, where
possible, or to EntrezIDs based upon the Ilumina annotation file
if Ensembl annotation was unavailable. Sylamer [54] was used to
count the number of miRNA seed sequences associated with miR-
25 in the 39UTR of the annotated transcripts. The final miRNA
target list comprises of those transcripts from this potential target
list with one or more 7mer[1A] or 7mer[2] seed sequence within
their annotated 39UTRs. This list was further refined through a
comparison to those genes whose expression changed between
heterozygote Dgcr8 cells with two gene traps in the same allele of
Dgcr8 and homozygous mutant cells with a gene trap cassette in
each allele of Dgcr8. A linear model was fitted across all of the
heterozygous and homozygous mutant arrays and a fifth set
incorporating wild-type ES cells (E14). Using the same set of
refined probes described and considering each of the heterozygous
lines and homozygous mutant lines with equal weight the limma
[74] package in bioconductor [72] was used to determine the
relative expression change for each probe and corresponding gene
between the cell lines of differing genotype.
Microarray data in this study can be accessed at:
E-MTAB-409 ,http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-409.
E-MTAB-418 ,http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-418.
Quantitation of miRNA
Quantitative real time PCR was performed using Taqman
Gene Expression assays (Applied Biosystems) according to
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manufacture’s instructions. The assay was custom designed using
the Primer Express Software 3.0 (Applied Biosystems). The
amount of target RNA was determined from the appropriate
standard curve and normalized relative to Gapdh mRNA. Primer
sequences are shown in Table S1. For mature miR-25 real time
PCR analysis, we used a kit from the Taqman MicroRNA assays
(Applied Biosystems). miR-25 expression was normalized against
expression of Sno202 (Applied Biosystems).
Sylamer target enrichment analysis
Sylamer utilizes the over- and under-representation P-values in
nested bins across a ranked sequence universe. It is optimized for
four letter alphabets (i.e. DNA/RNA) and computes P-values for
all words of a fixed length. The method has been tested on
different miRNA expression databases. A convenient post-
processing step is to plot the Sylamer output as lines of log-
transformed P-values across all bins, giving a comprehensive view
of word distribution behaviour across the sequence universe.
Luciferase plasmid construction
The Wwp2 39UTR was amplified using primers Wwp2-F: 59-
TTTAACTCGAGCT-GAGGCTGCTGTCTCACAC-39 and
Wwp2-R: 59-AAGCCGCGGCCGCGGCTGCTG-ATTCTT-
TATTGC-39. The amplified fragment was digested using XhoI
and NotI and ligated the psiCheck-2 renilla luciferase reporter
plasmid (Promega). For the mutagenesis reactions, Quick Change
Lightning Mutagenesis Kit (Strategne) was used. The mutagenic
primers were Wwp2-mF: 59-TCGGTATTGC-CAGTTTCTTG-
TAGACTAAAGAATCAGCAGC-39 and Wwp2-mR: 59-GCTG-
CT-GATTCTTTAGTCTACAAGAAACTGGCAATACCGA-39.
Following the same cloning strategy, the Fbxw7 39UTR was
amplified using primers Fbxw7-F: 59- TTTAACTCGAGAAAGCA-
GACATGATGAATTTTG-39 and Fbxw7-R: 59– AAGCC-
GCGGCCGCTAACATGAAAAAACACATTTTAT-39. For the
mutagenesis reactions, the following primers were used: Fbxw7-
mF1: 59 – GACGACTC-TCTAAATCCAACCAGGTGGAAT-
TATTCTTTG-39 and Fbxw7-mR1: 59 – CAAAG-AATAATTC-
CACCTGGTTGGATTTAGAGAGTCGTC-39 for site 1. Fbxw7-
mF2: 59- CTTATAACTTAAGTGGAATAAAATGTGTTTTTT-
CATGTTAGCGGC-39 and Fbxw7-mR2: 59-GCCGCTAACAT-
GAAAAAACACATTTTATTCCACTTAAG-TTATAAG-39 for
site 2.
All plasmids were verified by sequencing.
Luciferase assays
Luciferase reactions were performed in 96 well plates. HeLaS3
cells were transfected using the Lipofectamin 2000 reagents
(Invitrogen) with 5 ng of the Wwp2 or the Fbxw7 39UTR
plasmids. This value was derived after a concentration curve of the
plamid was tested. A miR-25 mimic (Dharmacon) was added at a
concentration of 20 nM. Different concentrations were tested and
20 nM was chosen as the lowest concentration to cause significant
inhibition (data not shown). Reporter activity was analysed
24 hours after transfection with the Dual-Luciferase Reporter
Assay System (Promega). Expression data are given as a ratio, with
the Renilla reporter normalized against the luciferase reporter
values.
Data analysis
Data are presented as mean 6SEM. Comparison between
groups were performed using one-way ANOVA followed by the
Newman-Keuls post test to determine statistical significance. A P
value of ,0.05 was taken as statistically significant.
Supporting Information
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